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a b s t r a c t
The transcription factor Pitx2c is expressed in primordial visceral organs in a left-right (L-R) asymmetric
manner and executes situs-speciﬁc morphogenesis. Here we show that Pitx2c is also L-R asymmetrically
expressed in the developing mouse limb. Human PITX2c exhibits the same transcriptional activity in the
mouse limb. The asymmetric expression of Pitx2c in the limb also exhibits dorsal-ventral and anterior-
posterior polarities, being conﬁned to the posterior-dorsal region of the left limb. Left-sided Pitx2c
expression in the limb is regulated by Nodal signaling through a Nodal-responsive enhancer. Pitx2c is
expressed in lateral plate mesoderm (LPM)–derived cells in the left limb that contribute to various limb
connective tissues. The number of Pitx2cþ cells in the left limb was found to be negatively regulated by
Pitx2c itself. Although obvious defects were not apparent in the limb of mice lacking asymmetric Pitx2c
expression, Pitx2c may regulate functional L-R asymmetry of the limb.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Left-right (L-R) asymmetry of the vertebrate body is most
obvious for visceral organs such as the heart and stomach. The
process by which L-R asymmetry of visceral organs in the mouse is
established can be divided into four phases: (1) initial determina-
tion of L-R polarity, which is achieved as a result of leftward ﬂuid
ﬂow in the node (nodal ﬂow); (2) transfer of an asymmetric signal
from the node to lateral plate mesoderm (LPM); (3) asymmetric
expression of signaling molecules such as Nodal and Lefty as well
as of the transcription factor Pitx2 in LPM; and (4) asymmetric
morphogenesis governed by Pitx2 (Shiratori and Hamada, 2006).
Visceral organs begin to develop anatomic asymmetries in
distinct manners, such as directional looping for the heart and
digestive tract, differential lobation for the lung, and unilateral
regression for the vascular system. The main player in regulation of
asymmetric organogenesis is Pitx2 (Davis et al., 2008; Guioli and
Lovell-Badge, 2007; Ishimaru et al., 2008; Logan et al., 1998; Lu
et al., 1999; Piedra et al., 1998; Shiratori et al., 2006; Yashiro et al.,
2007; Yoshioka et al., 1998), the asymmetric expression of which is
induced by Nodal (Shiratori et al., 2001). The cellular basis of
asymmetric organogenesis is not well understood, however. It thus
remains unclear how each organ primordium interprets L-R infor-
mation, or how Pitx2 regulates situs-speciﬁc morphogenesis of
various visceral organs by seemingly different cellular mechanisms.
We now show that Pitx2c is asymmetrically expressed in the
developing mouse forelimb. Although its biological signiﬁcance is
not clear, this asymmetric gene expression may be linked to
functional L-R asymmetry of the limb.
Material and methods
Animal care and treatment
Animals were maintained in the Animal Facility of Graduate
School of Frontier Biosciences, Osaka University under 14:10 h
light/ dark cycle and were provided with food and water ad
libitum. All experiments were approved by the Institutional Animal
Care and Use Committee of the Osaka University.
Generation of lacZ constructs and transgenic mouse assays
Permanent transgenic mouse lines harboring 17-P1 (P26 and P44)
or Pitx2-Cre (PC16) were established previously, and the ASE0.9-P1 and
Human PITX2 ASE-lacZ constructs were previously described (Shiratori
et al., 2001, 2006). The Pitx2c-lacZ/BAC, Pitx2c-lacZ/BAC2, and Pitx2c-
lacZ/BAC3 transgenes, in which lacZ is positioned downstream of the
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Pitx2c promoter, were constructed from BAC clones containing mouse
Pitx2 (RP23-194G9, RP24-358M10, and RP23-317I22, respectively)
with the use of the highly efﬁcient phage-based recombination system
for Escherichia coli (Copeland et al., 2001). The Pitx2c-lacZ/BAC-ΔASE
transgene was constructed by deleting the 0.6-kb left side-speciﬁc
enhancer (ASE) region from Pitx2c-lacZ/BAC. The Human PITX2c-lacZ/
BAC transgene, in which lacZ is inserted downstream of PITX2c
promoter, was constructed from BAC clone containing human PITX2
(RP11-729A1). BAC DNA was prepared for microinjection as described
(Gong et al., 2003). Various transgenes were also constructed from a
vector (P1-lacZ) consisting of the 1.3-kb P1 promoter region of mouse
Pitx2c linked to lacZ. Test fragments of Pitx2 ASE were individually
subcloned into P1-lacZ at the 30 end of lacZ. For generation of site-
directed mutants, ASE fragments were ﬁrst subcloned in pKF18
(Takara). Fragments containing mutated C1 (CTCTGGGGCGA-CTA-
GATTTAGA) and C2 (TGGGGGGTGGGGG-CTTAATTGTTAAC) sites
were similarly subcloned into the P1-lacZ vector. Cryptic-CreER and
Pitx2c-CreER were constructed by linking CreER (Danielian et al., 1998)
either to an 11-kb genomic fragment containing the LPM-speciﬁc
enhancer of mouse Cryptic and the Hsp68 promoter (Oki et al., 2007)
or to a 7.5-kb genomic fragment containing ASE and the P1 promoter
of mouse Pitx2c, respectively. Transgenic mice were generated by
injection of these various lacZ constructs into the pronucleus of
fertilized eggs as described previously (Shiratori et al., 2001). Embryos
were recovered at the indicated stages and were examined for lacZ
expression by X-gal staining as well as for the presence of transgenes
with the polymerase chain reaction. Permanent lines harboring Pitx2c-
lacZ/BAC, Pitx2c-CreER, or Cryptic-CreER (PZB24, PCE23, and CCE28,
respectively) were generated.
Generation of a Pitx2clacZ knock-in mouse
A targeting vector was designed to introduce lacZ downstream
of the Pitx2c promoter (Fig. S1). Targeted embryonic stem cells
were cultured and used for aggregation with ICR fertilized eggs at
the 8- to 16-cell stage by standard methods. Male chimeras were
bred with CAG-Flpe females (Kanki et al., 2006) to yield male
offspring without the PGK-neo sequence, which were then mated
with ICR females. The resulting heterozygous embryos were used
for X-gal staining.
Tamoxifen treatment
Rosa26R mice and mTmG mice (Soriano, 1999, Muzumdar et al.,
2007) obtained from The Jackson Laboratory or CAG-CAT-EGFP
(Kawamoto et al., 2000) mice provided by Jun-ichi Miyazaki
(Osaka University) were crossed with Pitx2c-CreER or Cryptic-
CreER mice. Tamoxifen (2.5 mg, Sigma) was mixed vigorously with
250 ml of sesame oil and administered to pregnant females by oral
gavage at the indicated developmental stages.
In situ hybridization and immunohistoﬂuorescence analysis
Whole-mount in situ hybridization was performed according to
standard protocols with a probe speciﬁc for all isoforms of Pitx2.
For ﬂuorescence in situ hybridization or immunohistoﬂuorescence
staining, embryos at E9.5 to E14.5 were ﬁxed in 4% paraformalde-
hyde, immersed in phosphate-buffered saline containing 30%
sucrose, and then embedded in OCT compound for preparation
of frozen sections (thickness of 10 μm). In situ hybridization was
performed according to standard protocols with 2,4-dinitrophe-
nol– or digoxigenin-labeled riboprobes speciﬁc for Pitx2, LacZ, or
EGFP mRNAs. Hybridized complexes were detected as Cy3 or Cy5
ﬂuorescence with the use of a tyramide signal ampliﬁcation system
(Perkin-Elmer). Immunohistoﬂuorescence staining was performed
with rabbit antibodies to GFP (1:500 dilution, Molecular Probes),
chicken antibodies to β-galactosidase (1:500 dilution, Abcam), mouse
antibodies to skeletal muscle MHC (1:500 dilution; My32, Sigma),
and rabbit antibodies to phosphorylated histone H3 (1:500 dilution,
Merck). Immune complexes were detected with Alexa Fluor 488–
conjugated antibodies to rabbit IgG, Alexa Fluor 568–conjugated
antibodies to chicken IgG, or Alexa Fluor 647–conjugated antibodies
to mouse IgG (each at a dilution of 1:500, Molecular Probes). Sections
were examined with a laser-scanning confocal microscope (FV1000,
Olympus).
X-gal staining
LacZ transgenic embryos were stained with X-gal (5-bromo-4-
chloro-3-indolyl-β-D- galactopyranoside) as described previously
(Saijoh et al., 1999). E18.5 embryos were stained after the skin of
the limb had been removed. For histological analysis, some embryos
subjected to X-gal staining were embedded in parafﬁn, sectioned at a
thickness of 10 mm, and then counterstained with nuclear fast red.
Results
Pitx2c-lacZ transgenes are L-R asymmetrically expressed in the
developing limb
A Pitx2c-lacZ transgene (17-P1) that contains a 17-kb region of
the mouse Pitx2 gene with lacZ inserted immediately downstream
of the Pitx2c promoter (Fig. 1A) was previously found to manifest
L-R asymmetric expression in primordial visceral organs (Shiratori
et al., 2001). We also now show that 17-P1 is expressed in a L-R
asymmetric manner in the developing limb. This asymmetric
expression of 17-P1 was ﬁrst apparent in the forelimb bud at
embryonic day (E) 9.5 (Fig. 1B), was subsequently evident in the
forelimb and hindlimb at E11.5 (Fig. 1C), and persisted in the
forelimb and hindlimb until E14.5 (Fig. 1D). Expression of the
transgene exhibited not only L-R asymmetry but also dorsal-
ventral (D-V) and anterior-posterior (A-P) polarities. Staining with
the LacZ substrate X-gal was thus conﬁned to the dorsal region on
the posterior side in the left forelimb and hindlimb (Fig. 1B–E).
Similar asymmetric expression was also observed with a bacterial
artiﬁcial chromosome (BAC)–based Pitx2c transgene (Pitx2c-lacZ/
BAC) in which lacZ is again positioned downstream of the Pitx2c
promoter (Fig. 1F–M). The Pitx2c-lacZ/BAC embryos showed L-R
asymmetric expression in the posterior-dorsal region of the
developing limb as well as in primordial visceral organs at E9.5,
E11.5, E14.5, and E18.5 (Fig. 1F–M). At E14.5 and E18.5, the left-
sided expression of the transgene in the limb was apparent in
cartilage, the outer layer of bone, tendon, and dermis (Fig. 1J–M).
Four muscles around the radius and ulna—extensor carpi ulnaris,
extensor digitorum, extensor digiti minimi, and extensor indicis—
were also positive for X-gal staining (Fig. 1J–M). Muscle consists of
myotubes and intramuscular connective tissue. We detected X-gal
staining in cells negative for myosin heavy chain (MHC) of skeletal
muscle (Fig. 1N), suggesting that Pitx2c-lacZ/BAC is expressed in
intramuscular connective tissue rather than in myotubes (which
are derived from somites). LacZ mRNA was asymmetrically detected
in the limb of transgenic embryos with Pitx2c-lacZ/BAC at E11.5 and
E14.5 (Fig. S2), suggesting that Pitx2c-lacZ/BAC is asymmetrically
transcribed until later stage of limb development.
Endogenous Pitx2c is L-R asymmetrically expressed in the forelimb
bud
In the previous study (Marcil et al., 2003), L-R asymmetric
expression of Pitx2 protein was not detected in the limb buds at
E10.5 and E11.5. To examine endogenous Pitx2c expression in the
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Fig. 1. Expression of Pitx2c-lacZ transgenes in the developing mouse limb. (A) The structure of the 17-P1 lacZ construct is shown below that of the genomic region containing Pitx2.
Exons (1, 2, 3, 1c, 4, and 5), two transcription initiation sites (P1 and P2), and the enhancer for asymmetric expression (ASE) are indicated. (B–M) X-gal staining of E9.5 (B, F), E11.5 (C, G),
E14.5 (D, E, H–K), and E18.5 (L, M) embryos harboring 17-P1 (B–E) or Pitx2c-lacZ/BAC (F–M). L-R, D-V, and A-P axes are indicated. I, II, III, IV, and V are digit numbers. Sections of the left
forelimb (E, I–K) were taken at the levels indicated by the lines in (D) and (H). In both the forelimb (ﬂ) and hindlimb (hl), lacZ expression is apparent only on the left side (B–D, F–H)
and is conﬁned to the dorsal region of the posterior side corresponding to digits III, IV, and V (E, I). The sections at the level of the radius and ulna (J, K) reveal Pitx2c-lacZ/BAC expression
in several tissues, including cartilage (black arrowhead), the outer layer of bone (yellow arrowhead), tendon (t), dermis (arrows), and muscle (ecu, extensor carpi ulnaris; ed, extensor
digitorum; edm, extensor digiti minimi; ei, extensor indicis). The E18.5 embryo harboring Pitx2c-lacZ/BAC (L, M) showed the same expression pattern as the E14.5 embryo. The staining
of bone (asterisk) is background due to endogenous β-galactosidase activity (L). (N) Immunoﬂuorescence staining of a section of the left forelimb of a Pitx2c-lacZ/BACmouse embryo at
E12.5 with antibodies to LacZ (red) and to skeletal muscle MHC (blue). The transgene is not expressed in myotomes. Scale bars: 200 μm. (O) X-gal staining of E11.5 embryo harboring
Human PITX2c-lacZ/BAC. Left side–speciﬁc expression of lacZ is apparent in both the forelimb (ﬂ) and hindlimb (hl), and is conﬁned to the posterior region (arrows). Scale bars: 1000 μm
(B–D, O), Scale bars: 200 μm (E, J–M).
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developing limb more precisely, we established a Pitx2clacZ knock-
in mouse (in which lacZ was introduced downstream of the Pitx2c
promoter) by gene targeting (Fig. S1). Pitx2clacZ/þ mouse embryos
manifested left-sided expression of the knock-in allele in primor-
dial visceral organs as well as bilateral expression in other organs
such as Rathke's pouch, the ﬁrst branchial arch, and limb muscles
(Fig. 2A, B, D–G). Pitx2clac/þZ mice also showed L-R asymmetric
lacZ expression in the forelimb bud at E9.5 (Fig. 2A and B), with the
expression being conﬁned to the posterior-dorsal region of the left
limb bud (Fig. 2C). Such asymmetric lacZ expressionwas also apparent
in the forelimb at E10.5, but it was not obvious at later stages
(Fig. 2D–F). Furthermore, we detected asymmetric expression of
endogenous Pitx2 in the forelimb bud at E9.5 by in situ hybridization.
Pitx2mRNAwas thus localized to the posterior region of the left limb
bud (Fig. 2H and I), as was lacZ expression in Pitx2clacZ/þ embryos.
These results suggested that asymmetric expression of 17-P1 and
Pitx2c-lacZ/BAC in the limb reﬂects that of endogenous Pitx2c.
Whereas the Pitx2clacZ allele recapitulates endogenous Pitx2c expres-
sion, both asymmetric and symmetric, 17-P1 and Pitx2c-lacZ/BAC
appear to monitor only asymmetric expression, likely because they
lack a transcriptional enhancer required for bilateral expression. To
test this, we examined two additional BAC transgenes (Pitx2c-lacZ/
BAC2 and Pitx2c-lacZ/BAC3) that contain different genomic regions.
Both transgenes manifested bilateral expression in addition to
asymmetric expression in the limb (Fig. S3). However, their bilateral
expression was weaker than the asymmetric expression (Fig. S3),
suggesting that transcriptional regulatory elements required for
bilateral expression reside in part outside of the regions contained
in the three BAC clones tested. We therefore adopted 17-P1 and
Pitx2c-lacZ/BAC for further study of asymmetric Pitx2c expression.
Fig. 2. Expression of endogenous Pitx2c in the developing limb. (A–F) X-gal staining of Pitx2clacZ/þ embryos at E9.5 (A–C), E10.5 (D, E), and E11.5 (F). Left side–speciﬁc
expression of lacZ is apparent in the forelimb bud of the E9.5 embryo (A, B). A section of the left forelimb bud at E9.5 revealed that lacZ expression is conﬁned to the posterior
region (C). At E10.5, left-sided lacZ expression is apparent only on the dorsal side of the forelimb (arrows), whereas bilateral expression in forelimb myoblasts also begins
(D, E). Only bilateral expression of lacZ is apparent in the limb of the E11.5 embryo (F). (G) Immunoﬂuorescence staining of a section of the left forelimb of a Pitx2clacZ/þ
embryo at E12.5 with antibodies to LacZ (red) and to skeletal muscle MHC (blue). Bilateral LacZ expression in the forelimb is apparent in myogenic cells. (H, I) Expression of
endogenous Pitx2 at E9.5 as revealed by whole-mount in situ hybridization (H) and ﬂuorescence in situ hybridization (section) (I) with a probe that recognizes mRNA for all
isoforms of Pitx2 (Pitx2a, Pitx2b, and Pitx2c). Pitx2 (red ﬂuorescence) is expressed in the left forelimb bud and is coexpressed with LacZ (blue ﬂuorescence) in a Pitx2c-lacZ/
BAC embryo (I). Scale bars: 1000 μm (A, D, F, H, I), Scale bars: 200 μm (C, G).
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Asymmetric expression of Pitx2c in the developing limb requires
Nodal signaling
Asymmetric expression of Pitx2c in primordial visceral organs is
regulated by Nodal signaling (Shiratori et al., 2001, 2006). To
investigate the regulation of asymmetric Pitx2c expression in the
developing limb, we ﬁrst examined the expression of 17-P1 and
Pitx2c-lacZ/BAC in various L-R mutant mice. In iv/iv embryos, node
cilia are immotile and fail to generate nodal ﬂow, resulting in
randomized laterality of visceral organs (Layton, 1976; Okada et al.,
1999). In inv/inv embryos, the situs of visceral organs is reversed
on the FVB background and is randomized on the B6 congenic
background (Tamakoshi et al., 2006). We found that the asym-
metric expression of 17-P1 in the limb was randomized both in
iv/iv embryos and in inv/inv embryos on the B6 congenic back-
ground (Fig. 3A–D, Table S1). The asymmetric expression of the
Pitx2clacZ allele in the forelimb buds of E9.5 embryos was also
randomized in iv/iv homozygotes (Fig. 3E and F, Table S1). These
results thus suggested that left side–speciﬁc expression of Pitx2c in
the limb is under the control of nodal ﬂow. Cryptic and Gdf1 are
cofactors essential for Nodal signaling, and left-sided expression of
Pitx2c in LPM at E8.2 is absent in Cryptic–/– and Gdf1–/– embryos. In
these mutant embryos, 17-P1 and Pitx2c-lacZ/BAC failed to give rise
to X-gal staining in the limb at E11.5 (Fig. 3G and H, Table S1).
Pitx2clacZ/þ ; Cryptic–/– embryos also failed to show asymmetric
expression of lacZ in the limb bud at E9.5 (Fig. 3I, Table S1).
Together, these data indicated that Nodal signaling is essential for
the asymmetric expression of Pitx2c in the developing limb.
ASE is a Nodal-responsive enhancer of Pitx2 that is essential
and sufﬁcient for asymmetric expression of Pitx2c in primordial
visceral organs (Shiratori et al., 2001). Deletion of a 0.6-kb region
containing ASE from Pitx2c-lacZ/BAC (giving rise to Pitx2c-lacZ/
BAC-ΔASE) abolished asymmetric X-gal staining in the limb at
E11.5 (Fig. S4A and D). Conversely, the construct ASE0.9-P1, which
contains ASE and the P1 promoter of Pitx2c linked to lacZ
manifested left side-speciﬁc expression in the developing limb.
However, the D-V and A-P polarities apparent with 17-P1 and
Pitx2c-lacZ/BAC were disrupted with ASE0.9-P1, as evident by the
presence of X-gal staining in the anterior-ventral and posterior
regions of the forelimb as well as the anterior region of the
hindlimb (Fig. S4A–C). These results indicated that ASE is essential
for L-R asymmetric expression of Pitx2c in the developing limb but
is insufﬁcient for posterior-dorsal speciﬁcity. In addition to ASE, a
region (region A) seemed to be required for the A-P and D-V
polarities of Pitx2c-lacZ expression (Fig. S4A–C).
Human PITX2c-lacZ transgene is also L-R asymmetrically expressed in
the developing mouse limb
The L-R asymmetric expression of Pitx2 in primordial visceral
organs is conserved among vertebrates. We examined whether
Human PITX2c-lacZ/BAC, in which lacZ is inserted downstream of the
PITX2c promoter, shows L-R asymmetric expression in the developing
mouse limb. Human PITX2c-lacZ/BAC indeed showed activity similar to
the mouse Pitx2c-lacZ/BAC. Thus, Human PITX2c-lacZ/BAC was also
expressed in the posterior-dorsal region of the left limb at E11.5
(Fig. 1O). These results suggested that human PITX2c also is L-R
asymmetrically expressed in the developing human limb.
Two conserved sequences, C1 and C2, in the ASE are essential for
asymmetric Pitx2c expression in the limb
Asymmetric Pitx2c expression in visceral organs requires FoxH1
binding sites and an Nkx2 binding site in the ASE. The former sites
are required for initiation of Pitx2c expression, whereas the latter
is required for its maintenance (Shiratori et al., 2001). When the
ASE region of Pitx2c was further examined, we found two sequences
(C1 and C2) that are conserved between mouse and human Pitx2
genes (Fig. S5). Deletion analysis (Fig. S5A and B) suggested that they
are essential for asymmetric Pitx2c expression in the limb.
Asymmetric Pitx2c expression in LPM-derived cells of the developing
limb
Mesenchymal cells of visceral organs that manifest asymmetric
Pitx2c expression at late somite stages are derived from LPM. We
examined whether Pitx2c expression in the developing limb occurs
in LPM-derived cells. We generated Cryptic-CreER transgenic mouse
that expresses CreER (a tamoxifen-activated form of Cre recombi-
nase) under the control of the LPM-speciﬁc enhancer of Cryptic (Oki
et al., 2007), to mark LPM-derived cells (Fig. S6). Treatment of
pregnant mice harboring Cryptic-CreER and the CAG-CAT-EGFP or
the mTmG reporter gene (Kawamoto et al., 2000, Muzumdar et al.,
2007) with tamoxifen at E7.5 resulted in the efﬁcient marking of
LPM-derived cells with enhanced green ﬂuorescent protein (EGFP) or
membrane-targeted GFP at all subsequent embryonic stages exam-
ined. Transgenic embryos harboring Pitx2c-lacZ/BAC, Cryptic-CreER
and CAG-CAT-EGFP were then exposed to tamoxifen at E7.5 and
dissected at E10.5 or E12.5. Cells positive for both LacZ and EGFP
were detected in the left forelimb at both E10.5 and E12.5 (Fig. 4A
and B, Table S2), suggesting that Pitx2c-lacZ/BAC is expressed in LPM-
derived cells of the forelimb. Some of the LacZþ cells are negative for
EGFP, which is probably due to the limited efﬁciency of cell labeling
by Cre-ER. Similarly, when Pitx2clacZ/þ embryos harboring both
Cryptic-CreER and mTmG were exposed to tamoxifen at E7.5, the
cells expressing LacZmRNA in the left forelimb were also positive for
membrane-targeted GFP at E9.5 (Fig. 4C and D). These results
indicated that Pitx2c is asymmetrically expressed in LPM-derived
mesenchymal cells of the developing limb.
To clarify whether expression of Pitx2c-lacZ/BAC is maintained
in LPM-derived cells from E8.2, we examined the fates of Pitx2c-
expressing cells with the use of a Pitx2c-CreER transgene. Embryos
harboring Pitx2c-CreER, CAG-CAT-EGFP and Pitx2c-lacZ/BAC trans-
genes were exposed to tamoxifen in utero at E8.2 and harvested at
E10.5 or E12.5. Only 20% of the EGFPþ cells in the left forelimb at
either E10.5 or E12.5 were LacZþ (Fig. 5A–D). When the embryos
were exposed to tamoxifen at E9.5, 70% of EGFPþ cells in the left
forelimb at E12.5 were LacZ– (Fig. 5E and F). These results
suggested that many of the cells expressing Pitx2c-lacZ/BAC at
E8.2 or E9.5 terminate its expression as development proceeds.
Fate of cells manifesting asymmetric Pitx2c expression in the limb bud
To clarify the fate of Pitx2c-expressing cells, we crossed Pitx2c-Cre
or Pitx2c-CreER mice with Rosa26R reporter mice, which express lacZ
in a Cre-dependent manner (Soriano, 1999). Whereas expression of
lacZ induced by Pitx2c-CreER and tamoxifen treatment at E9.5 was
apparent in the posterior-dorsal region of the left forelimb at E14.5
(Fig. 5G and H), that induced by Pitx2c-CreER and tamoxifen treatment
at E8.2 (Fig. 5I-L) or by Pitx2c-Cre (Fig. 5M and N) was detected in the
left limb without A-P and D-V polarities. These results indicated that,
whereas cells expressing Pitx2c in left LPM at E8.2 contribute to the
left forelimb without A-P and D-V polarities, those expressing Pitx2c
in the left forelimb bud at E9.5 contribute to various mesenchymal
tissues (cartilage, outer layer of bone, tendon, dermis, and muscle
connective tissue) in the posterior-dorsal region of the left forelimb.
Pitx2c inhibits cell proliferation in the developing limb in a
cell-autonomous manner
To elucidate the role of Pitx2c produced asymmetrically in the
developing limb, we examined the expression of Pitx2c-lacZ/BAC and
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Fig. 3. Expression of Pitx2c-lacZ transgenes and endogenous Pitx2c in the limb of L-Rmutants. (A–D) X-gal staining of iv/iv (A, B) and inv/inv (C, D) embryos harboring 17-P1 at E14.5. In
iv/iv embryos or inv/inv embryos on the B6 congenic background, lacZ expression in the limb was randomized (right-sided (A), bilateral (B and D), or right-sided in the forelimb and
left-sided in the hindlimb (C)). (E, F) X-gal staining of Pitx2clacZ/þ ; iv/iv embryos at E9.5. Asymmetric lacZ expression in the forelimb bud is randomized, with the arrowheads indicating
right-sided (E) and bilateral (F) expression. Scale bars: 1000 μm. (G) X-gal staining of a Gdf1 / embryo harboring 17-P1 at E11.5. Asymmetric lacZ expression is not apparent in left and
right limbs. (H) X-gal staining of a Cryptic / embryo harboring Pitx2c-lacZ/BAC at E11.5. Asymmetric lacZ expression is absent in left and right limbs. (I) X-gal staining of a Pitx2clacZ/þ;
Cryptic / embryo at E9.5. Asymmetric lacZ expression is lost in the forelimb bud. (J, K) Expression of endogenous Pitx2was examined at E9.5 by in situ hybridization with a probe for
Pitx2. Left-sided expression in the limb is apparent in Pitx2ΔASE/þ embryo (J) but absent in Pitx2ΔASE/ΔASE embryo (K). Scale bars: 1000 μm.
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the fate of Pitx2cþ cells in Pitx2ΔASE/ΔASE embryos, which lack
endogenous left-sided Pitx2 expression (Shiratori et al., 2006) includ-
ing that in the developing limb (Fig. 3J and K). Expression of Pitx2c-
lacZ/BAC in Pitx2ΔASE/ΔASE embryos was similar to that in the wild
type (Fig. S7). However, the progeny of Pitx2c-expressing cells in the
limb were increased in number in Pitx2ΔASE/ΔASE embryos. Pitx2c-
expressing cells were labeled at E9.5 with Pitx2c-CreER and Rosa26R
transgenes, and their progeny were examined at E14.5. Unexpectedly,
the number of LacZþ cells in the left forelimb was signiﬁcantly
higher in Pitx2ΔASE/ΔASE embryos than in Pitx2ΔASE/þ embryos,
whereas the number of LacZþ cells in the heart was similar for the
two genotypes (Fig. 6A–F, S). Similarly, when Pitx2c-expressing cells
were marked at E9.5 and examined at E12.5, or were labeled at E12.5
and examined at E14.5, the number of LacZþ cells in the left forelimb
was greater in Pitx2ΔASE/ΔASE embryos compared with Pitx2ΔASE/þ
embryos (Fig. 6G–R, T). These results suggested that Pitx2c negatively
regulates cell proliferation in the left forelimb in a cell-autonomous
manner.
Finally, we examined the proliferation of Pitx2c-lacZ/BAC–
expressing cells in the left forelimb directly by immunostaining
with antibodies to phosphorylated histone H3. LacZþ cells in the
extensor digiti minimi, one of the muscles that express Pitx2c-lacZ/
BAC in the forelimb at E14.5, showed a higher proliferation rate in
Pitx2ΔASE/ΔASE embryos than in Pitx2ΔASE/þ embryos both at E14.5
and at E12.5 (Fig. 6U). Again, these results indicated that Pitx2c
inhibits cell proliferation in the developing left forelimb in a cell-
autonomous manner.
Discussion
We have here shown that Pitx2c is L-R asymmetrically
expressed in the developing mouse limb. Although the limb is
considered a symmetric organ, our ﬁnding suggests that L-R
asymmetry, anatomic or functional, may exist in the limb.
The expression of both 17-P1 and Pitx2c-lacZ/BAC in the limb
exhibited A-P and D-V polarities in addition to L-R asymmetry,
with expression being conﬁned to the posterior-dorsal region of
the left limb. In addition to ASE, a region (region A) is required for
the A-P and D-V polarities. This region contains multiple ATTA
sequences, potential binding sites for Hox proteins, and two
consensus binding sequences for TCF/LEF proteins. A group of
Hox genes are expressed in the posterior region of the limb bud
while Wnt7a is expressed on the dorsal side of developing limb,
suggesting that such proteins may determine the A-P and D-V
speciﬁcity of asymmetric Pitx2c expression in the limb.
We found that asymmetric Pitx2c expression in the limb
depends on ASE and that two sequences (C1 and C2) located
in the ASE and conserved between mouse and human Pitx2
genes are essential for Pitx2c expression in the limb. Given that
both C1 and C2 contain the sequence TGGGG, a potential binding
site for Gli, Gli-related transcription factors may be required for
Pitx2c expression in the limb at developmental stages later than
E8.2. Thus, limb expression of Pitx2c is likely to receive regulatory
input from the Shh signaling derived from the posterior side of
limb bud.
Fig. 4. Origin of Pitx2c-expressing cells in the left limb. Pitx2c-lacZ/BAC; Cryptic-CreER; CAG-CAT-EGFP (A, B) and Pitx2clacZ/þ; Cryptic-CreER; mTmG (C, D) embryos were
exposed to tamoxifen in utero at E7.5 and then collected at E10.5 (A), E12.5 (B), or E9.5 (C, D). A higher magniﬁcation image of (C) is shown in (D). Sections of the left forelimb
were subjected either to immunoﬂuorescence staining with antibodies to GFP and to LacZ (A, B) or to ﬂuorescence in situ hybridization (ISH) with the LacZ probe coupled
with immunoﬂuorescence staining with an antibody to GFP (C, D). LPM-derived cells (green) are marked by the presence of EGFP (A, B) or menbrane-targeted GFP protein
(C, D), with some of these cells also being found to be positive for LacZ protein or mRNA (red). Scale bars: 100 μm (A, B, D), Scale bars: 400 μm (C).
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Pitx2c is expressed in LPM-derived cells in the left forelimb. Our
results suggest that LPM cells that express Pitx2c at E8.2 contribute
to the limb without A-P and D-V polarities. After E9.5, Pitx2c
expression is maintained only in the posterior-dorsal region of the
forelimb bud whereas many of Pitx2cþ cells gradually terminate
its expression as development proceeds (Fig. 7). We also found
that the proliferation rate of Pitx2c-lacZ/BAC expressing cells in the
left forelimb of Pitx2ΔASE/ΔASE embryos was higher than that for
Pitx2ΔASE/þ embryos, suggesting that Pitx2c negatively regulates
cell proliferation in a cell-autonomous manner. Such a mechanism
might be expected to allow precise determination of the number
of originally Pitx2cþ cells that will contribute to the posterior-
dorsal region of the left limb (Fig. 7). Pitx2 is known to regulate
cell proliferation. In the developing cardiac outﬂow tract and
pituitary gland, Pitx2 positively regulates cell proliferation by
serving as a competence factor for induction of cyclin D2 gene
transcription (Kioussi et al., 2002). Similarly, overexpression of
Pitx2c was found to promote proliferation of skeletal muscle
progenitor cells (Martinez-Fernandez et al., 2006). How then
might Pitx2c negatively regulate cell proliferation in the limb
bud? Given that the size of the left limb is indistinguishable
between wild-type and Pitx2ΔASE/ΔASE mice and that there is no
signiﬁcant difference in the percentage of proliferating cells in the
extensor digiti minimi of the left limb between Pitx2ΔASE/þ and
Pitx2ΔASE/ΔASE mice, the reduced number of Pitx2cþ cells in the
former may be compensated for by an increase in the number of
Fig. 5. Fate of Pitx2c-expressing cells in the left forelimb. (A–F) Mouse embryos harboring Pitx2c-lacZ/BAC, Pitx2c-CreER, and CAG-CAT-EGFP transgenes were exposed to
tamoxifen (Tmx) in utero at E8.2 (A–D) or E9.5 (E, F) and harvested at E10.5 (A, B) or E12.5 (C–F). Sections of the left forelimb of the embryos were subjected to
immunoﬂuorescence staining with antibodies to LacZ and to GFP. Many EGFPþ cells (green) do not express LacZ (red) regardless of the developmental stage for either
tamoxifen treatment or embryo harvesting. (G–N) Embryos harboring Pitx2c-CreER and Rosa26R (R26R) transgenes and exposed to tamoxifen in utero at E9.5 (G, H) or E8.2
(I-L) as well as those harboring Pitx2c-Cre and Rosa26R transgenes (M, N) were harvested at E10.5 (K), E12.5 (L) or E14.5 (G-J, M, N). Sections of the left forelimb of the
embryos were then stained with X-gal. Staining in the left forelimb either was apparent in several tissues including cartilage (black arrowheads), the outer layer of bone
(yellow arrowheads), tendon (t), dermis (arrows), and muscles (ecu, ed, edm, and ei) without A-P and D-V polarities (I–N), or was limited to these tissues in the posterior-
dorsal region (G, H). Scale bars: 500 μm.
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Pitx2c– cells without a change in the total number of Pitx2cþ plus
Pitx2c– cells. A cell competition mechanism (Levayer and Moreno,
2013) may thus operate between Pitx2cþ and Pitx2c– cells. For
example, Pitx2c may render a cell competent to respond to a
proliferation-suppressing activity produced by Pitx2c– cells.
Pitx1 is critical for establishing the hind limb bud. Interestingly,
Pitx1mutants largely lose the hind limbs, but the phenotype is less
severe on the left side. Furthermore, the left hindlimb becomes
smaller in the double mutant, Pitx1 /; Pitx2þ / mouse (Marcil
et al., 2003). Similarly the loss of Pitx1 in the limb ﬁeld is
responsible for reduction of the pelvic spines in Stickleback ﬁsh
(Shapiro et al., 2004) and loss of hindlimbs in Manatees (Shapiro
et al., 2006), in both cases with the right limb/spine being more
severely affected. These observations may be explained by asym-
metric expression of Pitx2c in the limb bud.
We examined the patterns of axons, blood vessels, and muscles
(containing tendons) in the mouse forelimb but were unable to
identify any reproducible L-R differences. We also did not detect
any morphological differences in the forelimb between wild-type
and Pitx2ΔASE/ΔASE mice. Given that overexpression of Pitx2a in the
developing forelimb mesenchyme induced abnormal tendon posi-
tioning (Holmberg et al., 2004), Pitx2c may be responsible for
generating previously unknown L-R asymmetry in the limb.
Interestingly, human PITX2c-lacZ transgene showed L-R asym-
metric expression in the mouse limb like mouse Pitx2c-lacZ
transgene did. Furthermore, two transcriptional regulatory sequences
required for asymmetric expression in the limb, the ASE and A
region, are highly conserved between mouse and human Pitx2
(Figs S2F, S7). Although it is not feasible to directly examine PITX2c
expression in the human limb, PITX2c may have similar expression
domains and function in the human limb.
Both Pitx2c-lacZ/BAC and 17-P1 were expressed in connective
tissue of four muscles—extensor carpi ulnaris, extensor digitorum,
extensor digiti minimi, and extensor indicis—that are located in the
posterior-dorsal region of the limb. The limb on the left side thus
contains cells that originally expressed Pitx2c in its posterior-dorsal
region, whereas that on the right side does not. Of interest, all of these
muscles are extensor muscles innervated by the deep branch of the
radial nerve. L-R asymmetry may exist when this nerve projects to the
posterior-dorsal region of the limb. It will therefore be important to
search for anatomic and functional L-R asymmetry of the neural
network including the deep branch of the radial nerve. Given that
Pitx2ΔASE/ΔASE mice die shortly after birth, precluding study of adult
animals, the generation of a mutant mouse that speciﬁcally lacks
asymmetric Pitx2c expression in the limb bud and survives to
adulthood might provide insight into the role of such expression.
Fig. 6. The number of Pitx2cþ cells in the left limb is determined by Pitx2c itself. (A–R) The left forelimb (A, D, G, J, M, P) or sections thereof (B, E, H, K, N, Q) as well as the
heart (C, F, I, L, O, R) of Pitx2ΔASE/þ (A–C, G–I, M–O) and Pitx2ΔASE/ΔASE (D–F, J–L, P–R) embryos harboring Pitx2c-CreER and Rosa26R exposed to tamoxifen in utero at E9.5 (A–F,
M–R) or E12.5 (G–L) were stained with X-gal at E14.5 (A–L) or E12.5 (M–T). The sections were collected at the levels indicated in the corresponding intact embryos. (S and T)
Percentage of LacZþ cells in muscles of the left forelimb of E14.5 embryos harboring Pitx2c-CreER and Rosa26R and exposed to tamoxifen in utero at E9.5 (S) or E12.5 (T).
Pitx2ΔASE/þ and Pitx2ΔASE/ΔASE embryos showing similar patterns of LacZ expression in the heart were evaluated. Data are means7SEM from more than three embryos for
each genotype from three independent litters, and more than 500 cells were counted per embryo (P value o0.05). (U) Percentage of LacZþ (Zþ) or LacZ– (Z–) cells that were
positive for phosphorylated histone H3 (pH3) in the extensor digiti minimi of the left forelimb in Pitx2ΔASE/þ and Pitx2ΔASE/ΔASE embryos harboring Pitx2c-lacZ/BAC at E12.5
and E14.5. Data are means7SEM from three embryos and more than 500 cells were counted per embryo (P value o0.05). ecu, extensor carpi ulnaris; ed, extensor
digitorum; edm, extensor digiti minimi. Scale bars: 500 μm.
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